Status:
RECRUITING
Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF
Lead Sponsor:
University of British Columbia
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
Brief Summary
This observational study intends to investigate health trends and data in cystic fibrosis patients all across Canada that are receiving modulator treatment so researchers can determine if CFTR treatme...
Eligibility Criteria
Inclusion
- Prescribed a CFTR modulator therapy and planning to commence modulator therapy within 30 days OR planning to switch modulator therapies within 30 days
- Participates in the Canadian Cystic Fibrosis Registry (CCFR)
- Informed consent by participant, or parent/legal guardian or assent
Exclusion
- Known contraindications to CFTR modulator therapy
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05200429
Start Date
November 1 2021
End Date
December 31 2027
Last Update
January 20 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Children's Hospital
Vancouver, British Columbia, Canada, V6H 3N1
2
St Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6